Ronald Frost - Feb 26, 2022 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Stock symbol
MMSI
Transactions as of
Feb 26, 2022
Transactions value $
-$126,288
Form type
4
Date filed
3/1/2022, 07:10 PM
Previous filing
Jun 16, 2021
Next filing
Aug 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Award $0 +6.63K +63.41% $0.00 17.1K Feb 26, 2022 Direct F1
transaction MMSI Common Stock, No Par Value Tax liability -$126K -1.94K -11.37% $65.03 15.1K Feb 28, 2022 Direct
holding MMSI Common Stock, No Par Value 16.3K Feb 26, 2022 By 401(k) plan F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Award $0 +8.09K $0.00 8.09K Feb 26, 2022 Common Stock 8.09K $65.03 Direct F3
holding MMSI Non-qualified stock options (right to buy) 9.68K Feb 26, 2022 Common Stock 9.68K $56.25 Direct F4
holding MMSI Non-qualified stock options (right to buy) 20K Feb 26, 2022 Common stock 20K $16.05 Direct F5
holding MMSI Non-qualified stock options (right to buy) 50K Feb 26, 2022 Common Stock 50K $28.20 Direct F6
holding MMSI Non-qualified stock options (right to buy) 40K Feb 26, 2022 Common Stock 40K $44.80 Direct F7
holding MMSI Non-qualified stock options (right to buy) 30K Feb 26, 2022 Common Stock 30K $55.73 Direct F8
holding MMSI Non-qualified stock options (right to buy) 16.7K Feb 26, 2022 Common Stock 16.7K $37.71 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee and Board of Directors that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/26/2020.
F2 Represents plan holdings as of 02/28/2022.
F3 Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
F4 Become exercisable in equal annual installments of 25% commencing 03/19/2022.
F5 Become exercisable in equal annual installments of 20% commencing 01/28/2017.
F6 Become exercisable in equal annual installments of 20% commencing 04/14/2018.
F7 Become exercisable in equal annual installments of 20% commencing 03/02/2019.
F8 Become exercisable in equal annual installments of 20% commencing 03/01/2020.
F9 Become exercisable in equal annual installments of 25% commencing 02/26/2021.